Vaterstetten, Germany

Elfi Biedermann

USPTO Granted Patents = 9 

Average Co-Inventor Count = 9.1

ph-index = 4

Forward Citations = 119(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Elfi Biedermann: Innovator in Cytostatic and Immunosuppressive Agents

Introduction

Elfi Biedermann is a prominent inventor based in Vaterstetten, Germany, recognized for her contributions to the field of medicinal chemistry. With a total of 9 patents to her name, Biedermann has focused her research primarily on the development of novel compounds that have significant implications in medical treatments, particularly in the areas of cytostatics and immunosuppressives.

Latest Patents

Among her latest patents, Biedermann's work on "Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents" stands out. This innovation relates to new pyridyl compounds, which are characterized by their unique structures involving aryl and/or heteroaryl residues. These compounds have shown promise in treating or preventing various types of tumors and in managing immune reactions associated with autoimmune diseases. Her research into "Pyridyl alkane acid amides as cytostatics and immunosuppressives" is also noteworthy, detailing methods for their synthesis, pharmaceutical formulations, and therapeutic applications.

Career Highlights

Throughout her career, Biedermann has made significant strides in pharmaceutical development. She has held positions at reputable companies, including Klinge Pharma GmbH and Astellas Deutschland GmbH, where she contributed her expertise in medicinal chemistry and drug development.

Collaborations

Biedermann has collaborated with distinguished professionals in her field, including Max Hasmann and Benno Rattel. These partnerships have facilitated the advancement of her research and the effective development of innovative therapeutics.

Conclusion

Elfi Biedermann's groundbreaking work in identifying and developing novel cytostatic and immunosuppressive agents positions her as a leading inventor in the pharmaceutical industry. Her commitment to research and development continues to pave the way for improved medical treatments, making notable contributions to the health and well-being of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…